Ongoing and planned health technology assessments of medical technologies in Belgium

Apr 2017

Belgian Health Care Knowledge Center issued information about ongoing and planned health technology assessments of medical technologies and IVD tests.

Ongoing assessments:

Clinical effectiveness of external cardiac defibrillators
MammaPrint and Oncotype for adjuvant chemotherapy decisions in early breast cancer
A framework for the managed introduction of 3D Printed medical devices in Belgium
Whole Genome Sequencing

Planned assessments:

Indications for bariatric surgery
Cost-effectiveness analysis of the use of drug eluting balloons for the treatment of intermittent claudication and lower limb ischemia
Techniques and indications for medical imaging: a time-driven activity based costing study

Although technology assessment is not directly connected to reimbursement decisions in Belgium, it has a clear role in decision-making by Belgian decision-making body, INAMI.

Further details can be found here for planned studies and here for ongoing assessments.

The latest related news

Rapid HTAs of five medical devices released in Tuscany

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Belgian KCE developing procedure for assessment of digital health technologies

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Assessments of monitoring and diagnostics of atrial fibrillation products released in Sweden

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

HTAs published by FinCCHTA in February 2022

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Theme survey on products for monitoring and diagnostics of sepsis launched by Swedish TLV

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.